Lymphoma SIG Podcast 10 - BSH 2025 Highlights in Hodgkin Lymphoma with Professor Graham Collinsfirst line therapy for Hodgkins lymphoma
May 23, 2025•12 min•Ep. 68
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, Professor Graham Collins shares with us the highlights in Hodgkin lymphoma from BSH 2025. He takes us through the ECHELON-1 trial, which led to the recent NICE approval of Brentuximab-AVD as a frontline treatment option for advanced stage Hodgkin lymphoma.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast